1 |
Efficacy and safety of apatinib plus docetaxel as the second or above line treatment in advanced nonsquamous NSCLC |
|
| | Qian Jiang,Ning-Ling Zhang,Dai-Yuan Ma,Bang-Xian Tan,Xin Hu,Xiang-Dong Fang | | | Medicine. 2019; 98(26): e16065 | | | [Pubmed] [Google Scholar] [DOI] | |
|